pioglitazone has been researched along with Aberrant Tissue in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shea, MK | 1 |
| Nicklas, BJ | 1 |
| Marsh, AP | 1 |
| Houston, DK | 1 |
| Miller, GD | 1 |
| Isom, S | 1 |
| Miller, ME | 1 |
| Carr, JJ | 1 |
| Lyles, MF | 1 |
| Harris, TB | 1 |
| Kritchevsky, SB | 1 |
1 trial available for pioglitazone and Aberrant Tissue
| Article | Year |
|---|---|
The effect of pioglitazone and resistance training on body composition in older men and women undergoing hypocaloric weight loss.
Topics: Abdominal Fat; Absorptiometry, Photon; Aged; Body Composition; Body Mass Index; Choristoma; Diet, Re | 2011 |